107
Views
5
CrossRef citations to date
0
Altmetric
Original Research

Development of a novel algorithm to determine adherence to chronic pain treatment guidelines using administrative claims

, , , , , & show all
Pages 327-339 | Published online: 08 Feb 2017

References

  • Institute of MedicineGrahamRMancherMWolmanDMGreenfieldSSteinbergEClinical Practice Guidelines We Can TrustWashington, DCNational Academies Press20112 Available from: https://www.nap.edu/catalog/13058/clinical-practice-guidelines-we-can-trustAccessed January 17, 2015
  • National Guideline Clearinghouse, Agency for Healthcare Research and Quality, United States Department of Health and Humans Services Available from: http://www.guideline.gov/index.aspxAccessed September 21, 2015
  • ThierSLYu-IsenbergKSLeasBFIn chronic disease, nationwide data show poor adherence by patients to medication and by physicians to guidelinesManag Care20081724857
  • KawamotoKAllen LaPointeNMSilveyGMAnstromKJEisensteinELLobachDFDevelopment and evaluation of an improved methodology for assessing adherence to evidence-based drug therapy guidelines using claims dataAMIA Annu Symp Proc Epub200739439818693865
  • MilchakJLCarterBLJamesPAArderyGMeasuring adherence to practice guidelines for the management of hypertension: an evaluation of the literatureHypertension200444560260815381676
  • KimJYKimHJJungSYUtilization of evidence-based treatment in elderly patients with chronic heart failure: using Korean Health Insurance claims databaseBMC Cardiovasc Disord2012126022849621
  • TheodorouMStafylasPKourlabaGKaitelidouDManiadakisNPapademetriouVPhysicians’ perceptions and adherence to guidelines for the management of hypertension: a national, multicentre, prospective studyInt J Hypertens2012201250382123251788
  • BergerJEThe ongoing challenge of pain medicationsAm J Pharm Benefits201466869
  • Chronic Pain Medical Treatment Guidelines Medical Treatment Utilization ScheduleAmerican Academy of Pain Medicine2008 Available from: http://www.painmed.org/files/medical-treatment-utilization-schedule-proposed-regulations.pdfAccessed January 17, 2015
  • O’RorkeJEChenIGenaoIPandaMCykertSPhysicians’ comfort in caring for patients with chronic nonmalignant painAm J Med Sci200733329310017301587
  • BakerCLZouKHSuJLong-acting bronchodilator use after hospi-talization for COPD: an observational study of health insurance claims dataInt J Chron Obstruct Pulmon Dis2014943143924833898
  • DiMartinoLDSheaAMHernandezAFUse of guideline-recommended therapies for heart failure in the Medicare populationClin Cardiol201033740040520641116
  • KirigayaDNakayamaTIshizakiTIkedaSSatohTManagement and treatment of osteoporosis in patients receiving long-term glucocorticoid treatment: current status of adherence to clinical guidelines and related factorsIntern Med201150222793280022082891
  • MilchakJLCarterBLArderyGPhysician adherence to blood pressure guidelines and its effect on seniorsPharmacotherapy20082884385118576899
  • BroekmansSDobbelsFMilisenKMorlionBVanderschuerenSMedication adherence in patients with chronic non-malignant pain: is there a problem?Eur J Pain200913211512318467138
  • ZhangWNukiGMoskowitzRWOARSI recommendations for the management of hip and knee osteoarthritis Part III: changes in evidence following systematic cumulative update of research published through January 2009Osteoarthritis Cartilage201018447649920170770
  • HochbergMAltmanRAprilKAmerican College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and kneeArthritis Care Res (Hoboken)201264446547422563589
  • KhannaDFitzgeraldJDKhannaPP2012 American College of Rheumatology Guidelines for Management of Gout Part I: systematic non-pharmacologic and pharmacologic therapeutic approaches to hyperuricemiaArthritis Care Res (Hoboken)2012641431144623024028
  • ZhangWDohertyMBardinTEULAR evidence based recommendations for gout. Part II: management. Report of a task force of the EULAR Standing Committee For International Clinical Studies Including Therapeutics (ESCISIT)Ann Rheum Dis200665101312132416707532
  • JordanKMCameronJSSnaithMBritish Society for Rheumatology and British Health Professionals in Rheumatology Guideline for the Management of GoutRheumatology20074681372137417522099
  • AttalNCruccuGBaronREFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revisionEur J Neurol20101791113e8820402746
  • American Academy of NeurologyTreatment of Painful Diabetic Peripheral Neuropathy2011 Available from: www.aan.comAccessed September 21, 2015
  • JongenJLHansGBenzonHTNeuropathic pain and pharmacological treatmentPain Pract201414113
  • DworkinRHO’ConnerABBackonjaMPharmacologic management of neuropathic pain: evidence based medicinePain2007132323725117920770
  • FitzcharlesMASte-MariePAGolenbergDL2012 Canadian Guidelines for the diagnosis and management of fibromyalgia syndrome: executive summaryPain Res Manag201318311912623748251
  • DeyoRACherkinDCCiolMAAdapting a clinical comorbidity index for use with ICD-9-CM administrative databasesJ Clin Epidemiol19924566136191607900
  • FarleyJFHarleyCRDevineJWA comparison of comorbidity measurements to predict healthcare expendituresAm J Manag Care200612211011716464140
  • DobsonABarnettAAn Introduction to Generalized Linear Models3rd edLondonChapman & Hall2008
  • McGlynnEAschSMAdamsJThe quality of health care delivered to adults in the United StatesN Engl J Med2003348262635264512826639
  • FitzcharlesMAGalimovaLJoveyRDUpdate: clinical challenges in the diagnosis and management of fibromyalgiaPract Pain Manage2011113
  • Colcrys™ (colchicine, USP) tablets [prescribing information]USATakeda Pharmaceuticals, Inc2012
  • PrMedrol* (methylprednisone, USP) tablets [prescribing information]CanadaPfizer Inc2015